Location History:
- New York, NY (US) (2020 - 2021)
- Rancho Santa Fe, CA (US) (2021)
- Rancho Sante Fe, CA (US) (2022)
- Tarrytown, NY (US) (2023)
Company Filing History:
7 out of 1,343 
1 out of 270 
Years Active: 2020-2025
Title: **The Innovative Contributions of Omri Gottesman**
Introduction
Omri Gottesman, an esteemed inventor located in New York, NY, has made significant contributions to the field of biotechnology. With a total of seven patents to his name, Gottesman's work primarily revolves around the exploration and application of HSD17B13 variants. His recent patents reflect a deep commitment to advancing medical science and improving diagnostics related to liver disease.
Latest Patents
One of Gottesman's latest patents is titled "HSD17B13 variants and uses thereof." This groundbreaking work encompasses compositions related to HSD17B13 variants, which includes nucleic acid molecules and polypeptides associated with these variants. His patent details methods for detecting the presence of the HSD17B13 rs72613567 variant in genomic DNA, allowing for innovative diagnostic techniques. Additionally, the invention includes methods for assessing the levels of various HSD17B13 transcripts and protein isoforms in biological samples, which can assist in determining a subject's susceptibility to liver disease or diagnosing existing liver conditions.
Career Highlights
Throughout his career, Omri Gottesman has collaborated with prominent organizations, particularly Regeneron Pharmaceuticals, Inc. and the Icahn School of Medicine at Mount Sinai. His work in these institutions has facilitated significant advancements in medical research, especially in the realm of genetic therapeutics and diagnostics.
Collaborations
Gottesman has worked alongside notable colleagues, including Frederick E. Dewey and Aris I. Baras. These collaborations have not only enhanced his research outcomes but have also contributed to the interdisciplinary approach necessary in the ever-evolving field of biotechnology.
Conclusion
Omri Gottesman's innovative spirit and unwavering dedication to research have positioned him as a leading figure in the medical and scientific communities. His patents, particularly those pertaining to HSD17B13 variants, underscore the potential for advancements in liver disease diagnostics and treatment. As he continues to push the boundaries of innovation, Gottesman remains a vital contributor to the ongoing quest for medical breakthroughs.